GlaxoSmithKline [GLAXO] vs Pfizer [PFIZER] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: GlaxoSmithKline wins in 6 metrics, Pfizer wins in 7 metrics, with 0 ties. Pfizer appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGlaxoSmithKlinePfizerBetter
P/E Ratio (TTM)58.1532.49Pfizer
Price-to-Book Ratio27.685.91Pfizer
Debt-to-Equity Ratio0.512.57GlaxoSmithKline
PEG Ratio55.0632.55Pfizer
EV/EBITDA47.6331.45Pfizer
Profit Margin24.74%33.65%Pfizer
Operating Margin33.07%35.66%Pfizer
EBITDA Margin33.07%35.66%Pfizer
Return on Equity49.75%19.65%GlaxoSmithKline
Return on Assets18.17%9.29%GlaxoSmithKline
Free Cash Flow$12.65B$6.32BGlaxoSmithKline
Dividend Yield1.65%1.27%GlaxoSmithKline
1-Year Return26.76%7.33%GlaxoSmithKline
Overview
Performance
Valuation
Financials
Short Interest
Dividends

GlaxoSmithKline vs Pfizer Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

GlaxoSmithKline vs Pfizer Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...